296
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999–2012

, , , , , , , & show all
Pages 195-200 | Received 09 Jul 2015, Accepted 22 Sep 2015, Published online: 03 Nov 2015

References

  • Tarantola A, Abiteboul D, Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control. 2006;34:367–375.
  • Tomkins S. Health Protection Agency Centre for Infections & Collaborators. Occupational Transmission of HIV. Summary of published reports. March 2005 edition. Data to December 2002. HIV & Sexually Transmitted Infections Department, 61 Colindale Avenue, London NW9 5 EQ, United Kingdom.
  • Seuffic-Burban S, Delarocque-Astagneau E, Abiteboul D, et al. Bloodborne Viruses in health care workers: prevention and management. J Clin Virol. 2011;52:4–10.
  • Council Directive 2010/32/EU of 10 May 2010 implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU. Off J Eur Union. 2010;53:66–72.
  • Young T, Arens FJ, Kennedy GE, et al. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev. 2007, issue 1. Art.No: CD002835. DOI:10.1002/14651858. DC002835.pub3.
  • Hamlyn E, Esterbrook P. Occupational exposure to HIV and the use of post-exposure prophylaxis. Occup Med. 2007;57:329–336.
  • Kuhar DT, Henderson DK, Kimberly A, et al. Updated US public health service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol. 2013;34:875–892.
  • Rapparini C, Saraceni V Lauria LM, et al. Occupational exposures to bloodborne pathogens among health care workers in Rio de Janeiro, Brazil. J Hosp Infect. 2007;65:131–137.
  • Hiransuthikul N, Hiransuthikul P, Kanasuk Y. Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand. J Hosp Infect. 2007;67:344–349.
  • Health Protection Agency, Health Protection Services; Public Health Wales, Public Health Agency Northern Ireland; Health Protection Scotland. Eye of the Needle. United Kingdom surveillance of significant occupational exposure to bloodborne viruses in healthcare workers. London: Health Protection Agency; 2012.
  • Landovitz RJ, Currier JS. Postexposure prophylaxis for HIV infection. NEJM. 2009;361:1768–1775
  • Lunding S, Katzenstein TL, Kronborg G, et al. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006. Sex Transmit Dis. 2010:37:49–52.
  • Lunding S, Balslev U, Pedersen C, et al. Postekspositionsprofylakse efter seksuel og erhvervsbetinget eksposition for hiv. Ugeskr Laeger. 2003;165:3709–3712.
  • Cowan S, Smith E. Forekomsten af hiv/aids i Danmark i perioden 1990-2005. Ugeskr Læger. 2006;168:2247–2252.
  • Eskandarani HA, Kehrer M, Christensen PB. No Transmission of bloodborne viruses among hospital staff despite frequent blood exposure. Dan Med J. 2014;61:A4907.
  • Vejledning om HIV (Human immundefekt virus) og hepatitis B og C virus. Forebyggelse af blodbåren smitte, diagnostik og håndtering i sundhedsvæsenet og på andre arbejdspladser. Sundhedsstyrelsen; 2013. Guideline from Danish Health Authority; [cited 2015 Oct 23]. Available from: www.sst.dk
  • HIV Postexposure Profylakse (PEP) 2015. Guideline from the Danish Society of Infectious Diseases; [cited 2015 Oct 23]. Available from: www.infmed.dk
  • EACS guidelines version 7.1 November 2014.
  • European Aids Clinical Society. Guidelines. Version 8.0, October 2015; [cited 2015 Oct 23]. Available from: www.eacsociety.com
  • Floret N, Ali-Brandmeyer O, L’Hériteau F, et al. Sharp decrease of reported occupational blood and body fluid exposures in French hospitals, 2003-2012: results of the French National Network Survey, AES-RAISIN. Infect Control Hosp Epidemiol. 2015;36:963–968.
  • Herida M, Larsen C, Lot F, et al. Cost-effectiveness of HIV post-exposure prophylaxis in France. AIDS. 2006;20:1753–1761.
  • i Goldschmidt RH. Occupational postexposure prophylaxis for HIV: the PEPline Perspective. Top HIV Med. 2010;18:174–177.
  • Ford N, Irvine C, Shubber Z, et al. Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis. AIDS. 2014;28:2721–2727.
  • Leal L, Leòn A, Torres B, et al. Tenofovir/Emtricitabine plus LPV/r vs MVC or Raltegravir for PEP: 2 Randomized trials. CROI 2015, Seattle, Washington; [cited 2015 Oct 23]. Available from: www.croiconference.org [Abstract 959].
  • McAllister J, Read P, McNulty A, et al. Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence. HIV Med. 2014:15:13–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.